posted on 2004-03-23, 00:00authored byMaria Lamothe, Fu-Jung Chang, Nataliya Balashova, Roman Shirokov, Annie Beuve
Soluble guanylyl cyclase (sGC) is a heterodimeric enzyme formed by an α subunit and a β
subunit, the latter containing the heme where nitric oxide (NO) binds. When NO binds, the basal activity
of sGC is increased several hundred fold. sGC activity is also increased by YC-1, a benzylindazole allosteric
activator. In the presence of NO, YC-1 synergistically increases the catalytic activity of sGC by enhancing
the affinity of NO for the heme. The site of interaction of YC-1 with sGC is unknown. We conducted a
mutational analysis to identify the binding site and to determine what residues were involved in the
propagation of NO and/or YC-1 activation. Because guanylyl cyclases (GCs) and adenylyl cyclases (ACs)
are homologous, we used the three-dimensional structure of AC to guide the mutagenesis. Biochemical
analysis of purified mutants revealed that YC-1 increases the catalytic activity not only by increasing the
NO affinity but also by increasing the efficacy of NO. Effects of YC-1 on NO affinity and efficacy were
dissociated by single-point mutations implying that YC-1 has, at least, two types of interaction with sGC.
A structural model predicts that YC-1 may adopt two configurations in one site that is pseudosymmetric
with the GTP binding site and equivalent to the forskolin site in AC.